CORONA REMEDIES
Back to Balance Sheet
|
CORONA REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹12 Cr | ₹8.30 Cr | ₹4.29 Cr | ₹-4.25 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CORONA REMEDIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹12 Cr |
| Mar2025 | ₹8.30 Cr |
| Mar2024 | ₹4.29 Cr |
| Mar2023 | ₹-4.25 Cr |
How is Deferred Tax Assets / Liabilities of CORONA REMEDIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹12 Cr | 46.51 | |
| Mar2025 | ₹8.30 Cr | 93.65 | |
| Mar2024 | ₹4.29 Cr | Positive | |
| Mar2023 | ₹-4.25 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,851.4 Cr | 2.5% | 2.6% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 2.5% |
2.6% |
|
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses